Aveo pharmaceuticals, inc. (AVEO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Collaboration and licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

2,532

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues:
Revenues

784

764

25,717

703

1,611

1,483

2,467

433

1,026

82

4,614

351

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

2,532

-

992

193

1,203

3,598

15,158

134

134

115

873

1,846

15,289

323

323

324

323

15,531

1,018

1,877

860

1,096

3,585

26,554

133,614

6,222

15,622

Operating expenses:
Research and development

7,826

4,512

3,983

2,611

6,852

5,201

5,160

4,887

5,404

5,676

4,666

6,881

7,956

7,683

4,444

5,604

5,972

3,873

4,466

1,841

2,695

8,702

8,485

9,300

11,767

11,889

19,414

16,203

20,962

24,033

21,099

21,450

24,776

18,542

20,098

25,078

38,017

20,252

25,997

General and administrative

3,672

2,886

2,884

2,986

2,455

2,625

2,719

2,827

2,610

2,404

2,101

2,302

2,331

1,870

2,141

1,731

2,463

1,848

2,225

2,889

3,255

3,104

5,084

4,846

5,555

4,499

4,440

7,324

12,449

9,463

9,300

9,186

8,983

6,986

6,582

6,371

9,228

3,611

3,835

Settlement costs (Note 13)

-

-

-

-

-

0

0

-709

42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring and lease exit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

25

4,333

1,302

1,403

5,165

3,859

4

77

7,869

67

-

-

-

-

-

-

-

-

-

-

Operating expenses, total

11,498

7,398

6,867

5,597

9,307

7,826

7,879

7,005

8,056

10,153

6,767

9,183

10,287

9,553

6,585

7,335

8,435

9,721

6,691

4,755

10,283

13,108

14,972

19,311

21,181

16,392

23,931

31,396

33,478

36,129

30,399

30,636

33,759

25,528

26,680

31,449

47,245

23,863

29,832

Loss from operations

-10,714

-6,634

18,850

-4,894

-7,696

-6,343

-5,412

-6,572

-7,030

-10,071

-2,153

-8,832

-7,755

-9,426

-5,593

-7,142

-7,232

-6,123

8,467

-4,621

-10,149

-12,993

-14,099

-17,465

-5,892

-16,069

-23,608

-31,072

-33,155

-20,598

-29,381

-28,759

-32,899

-24,432

-23,095

-4,895

86,369

-17,641

-14,210

Other income, net:
Interest expense, net

315

333

467

451

564

570

579

549

493

637

655

530

551

561

551

468

369

413

531

626

716

834

439

502

581

676

756

825

870

888

888

880

845

925

953

946

1,012

1,029

725

Change in fair value of PIPE Warrant liability

-2,648

-2,506

1,954

-2,210

-8,815

-26,431

16,172

-11,125

1,465

-14,207

23,538

23,925

484

-

-1,178

996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-44

-22

-209

-14

-37

98

-2

7

-3

32

-51

-101

-32

46

-66

299

-7

62

11

-56

10

-582

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

4

10

16

23

26

35

41

38

101

159

199

195

168

99

65

52

28

Other income, net

2,333

2,173

-2,421

1,759

8,251

1,730

-16,751

10,576

-1,958

-637

-24,193

-24,455

-1,035

3,822

627

-1,464

-378

-462

-553

-835

-725

-901

-337

-494

-558

-656

-698

-841

-930

-882

-741

-787

-347

-737

-723

-836

-1,003

-967

-1,279

Net income (loss) before provision for income taxes

-

-

-

-

-

-

-

-

-

3,499

-26,346

-33,287

-8,790

-5,604

-4,966

-8,606

-7,610

-6,585

7,914

-5,456

-10,874

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income taxes

-

-

-

-

-

-

-

-

-

0

51

0

50

1

0

0

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss)

-8,381

-4,461

16,429

-3,135

555

21,818

-22,163

4,004

-8,988

3,499

-26,397

-33,287

-8,840

-5,605

-4,966

-8,606

-7,710

-6,585

7,914

-5,456

-10,874

-13,894

-14,436

-17,959

-6,450

-16,725

-24,306

-31,913

-34,085

-21,480

-30,122

-29,546

-33,246

-25,169

-23,818

-5,731

85,366

-18,608

-15,489

Net loss per share - basic and diluted

-

-

-

-

-

-

-

-

-

-

-0.22

-

-0.12

-

-0.07

-0.13

-0.13

-

-

-0.10

-0.21

-

-

-0.35

-0.12

-0.32

-0.47

-0.62

-0.69

-0.50

-0.69

-0.68

-0.77

-

-

-

-

-

-

Weighted average number of common shares outstanding basic and diluted

-

-

-

-

-

-

-

-

-

-

118,006

-

76,246

-

75,861

66,917

58,166

-

-

55,164

52,638

-

-

51,663

51,634

-

-

-

-

43,490

43,430

43,322

43,254

-

-

-

-

-

-

Basic net income (loss) per share
Net income (loss) per share

-0.52

-0.28

0.10

-0.02

0.04

0.18

-0.18

0.03

-0.08

0.03

-

-0.30

-

-

-

-

-

-

0.14

-

-

-

-0.28

-

-

-

-

-

-

-

-

-

-

-0.90

-0.55

-0.16

2.38

-0.60

-0.50

Weighted average number of common shares outstanding

16,081

16,077

160,744

159,020

13,230

124,395

120,138

118,940

118,840

118,323

-

110,550

-

-

-

-

-

-

56,794

-

-

-

51,771

-

-

-

51,443

51,312

49,380

-

-

-

-

43,213

43,017

36,849

35,781

30,889

30,822

Diluted net income (loss) per share
Net income (loss) per share

-0.52

-0.28

0.10

-0.02

-0.62

-0.03

-0.18

-0.06

-0.08

-0.08

-

-0.30

-

-

-

-

-

-

0.14

-

-

-

-0.28

-

-

-

-

-

-

-

-

-

-

-0.83

-0.55

-0.16

2.28

-0.60

-0.50

Weighted average number of common shares and dilutive common share equivalents outstanding

-

-

-

-

-

-

-

-

-

-

-

110,550

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of common shares and dilutive common share equivalents outstanding

16,081

16,077

160,826

159,020

13,283

133,580

120,138

128,692

118,840

130,108

-

-

-

-

-

-

-

-

57,016

-

-

-

51,771

-

-

-

-

-

-

-

-

-

-

48,543

43,017

36,849

37,483

30,889

30,822

Collaboration and Licensing Revenue
Revenues

493

493

25,494

493

1,454

1,296

2,335

336

980

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Partnership Royalties
Revenues

291

271

223

210

157

187

132

97

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-